Birdwatch Note
2024-08-01 23:20:43 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
イマネ・ケリフ選手はトランス女性ではありません。昨年度の失格は遺伝子検査で男性ホルモン値が高かった為ですが、性分化疾患やアンドロゲン過剰症の可能性があります。 https://brujulaintersexual.org/2023/04/07/pronunciamiento-contra-la-descalificacion-de-la-boxeadora-argelina-imane-khelif/ 性分化疾患とは http://jspe.umin.jp/public/seibunka.html アンドロゲン過剰症とは https://www.shouman.jp/disease/details/05_28_060/ 2024パリオリンピックはトランス女性の出場選手の指針として12歳以前に性転換手術をしたものとしており、実質的にトランス女性の出場は非常に難しくなっています。 https://www.newsweekjapan.jp/stories/culture/2024/07/post-105020.php https://www.thenation.com/article/society/trans-athletes-paris-olympics/tnamp/
Written by E533AFD67A238F48ED36690F34768AA5E24FD844276EED2A8044CF7F0144D639
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819054256357605768
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819151301697327157
- noteId - 1819151301697327157
- participantId -
- noteAuthorParticipantId - E533AFD67A238F48ED36690F34768AA5E24FD844276EED2A8044CF7F0144D639 Participant Details
- createdAtMillis - 1722554443178
- tweetId - 1819054256357605768
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- イマネ・ケリフ選手はトランス女性ではありません。昨年度の失格は遺伝子検査で男性ホルモン値が高かった為ですが、性分化疾患やアンドロゲン過剰症の可能性があります。 https://brujulaintersexual.org/2023/04/07/pronunciamiento-contra-la-descalificacion-de-la-boxeadora-argelina-imane-khelif/ 性分化疾患とは http://jspe.umin.jp/public/seibunka.html アンドロゲン過剰症とは https://www.shouman.jp/disease/details/05_28_060/ 2024パリオリンピックはトランス女性の出場選手の指針として12歳以前に性転換手術をしたものとしており、実質的にトランス女性の出場は非常に難しくなっています。 https://www.newsweekjapan.jp/stories/culture/2024/07/post-105020.php https://www.thenation.com/article/society/trans-athletes-paris-olympics/tnamp/
Note Ratings
| rated at | rated by | |
| 2024-08-02 00:30:30 -0500 | Rating Details | |
| 2024-08-02 00:21:51 -0500 | Rating Details | |
| 2024-08-02 00:03:53 -0500 | Rating Details | |
| 2024-08-01 23:43:48 -0500 | Rating Details | |
| 2024-08-01 23:27:13 -0500 | Rating Details | |
| 2024-08-01 22:44:36 -0500 | Rating Details | |
| 2024-08-01 22:20:37 -0500 | Rating Details | |
| 2024-08-01 22:17:58 -0500 | Rating Details | |
| 2024-08-01 22:03:58 -0500 | Rating Details | |
| 2024-08-01 21:43:34 -0500 | Rating Details | |
| 2024-08-01 21:33:11 -0500 | Rating Details | |
| 2024-08-01 21:23:41 -0500 | Rating Details | |
| 2024-08-01 21:19:55 -0500 | Rating Details | |
| 2024-08-01 21:19:06 -0500 | Rating Details | |
| 2024-08-01 21:07:55 -0500 | Rating Details | |
| 2024-08-01 20:49:04 -0500 | Rating Details | |
| 2024-08-01 20:39:55 -0500 | Rating Details | |
| 2024-08-01 20:28:03 -0500 | Rating Details | |
| 2024-08-01 20:22:29 -0500 | Rating Details | |
| 2024-08-01 20:09:49 -0500 | Rating Details | |
| 2024-08-01 20:09:04 -0500 | Rating Details | |
| 2024-08-01 20:00:52 -0500 | Rating Details | |
| 2024-08-01 20:00:08 -0500 | Rating Details | |
| 2024-08-01 19:58:17 -0500 | Rating Details | |
| 2024-08-01 19:52:15 -0500 | Rating Details | |
| 2024-08-01 19:51:05 -0500 | Rating Details | |
| 2024-08-01 19:40:05 -0500 | Rating Details | |
| 2024-08-01 19:36:21 -0500 | Rating Details | |
| 2024-08-01 19:35:48 -0500 | Rating Details | |
| 2024-08-01 19:30:25 -0500 | Rating Details | |
| 2024-08-01 19:27:27 -0500 | Rating Details | |
| 2024-08-01 19:19:12 -0500 | Rating Details | |
| 2024-08-01 19:16:54 -0500 | Rating Details | |
| 2024-08-01 19:16:06 -0500 | Rating Details | |
| 2024-08-01 19:14:58 -0500 | Rating Details | |
| 2024-08-01 19:09:42 -0500 | Rating Details | |
| 2024-08-01 19:05:02 -0500 | Rating Details | |
| 2024-08-01 18:54:41 -0500 | Rating Details | |
| 2024-08-01 18:54:24 -0500 | Rating Details | |
| 2024-08-01 18:54:23 -0500 | Rating Details | |
| 2024-08-01 18:43:20 -0500 | Rating Details | |
| 2024-08-01 18:41:43 -0500 | Rating Details | |
| 2024-08-01 18:36:16 -0500 | Rating Details | |
| 2024-08-01 18:31:56 -0500 | Rating Details | |
| 2024-08-01 18:31:09 -0500 | Rating Details | |
| 2024-08-01 18:23:32 -0500 | Rating Details | |
| 2024-08-01 22:34:37 -0500 | Rating Details | |
| 2024-08-01 22:24:06 -0500 | Rating Details | |
| 2024-08-01 22:17:36 -0500 | Rating Details | |
| 2024-08-01 20:53:46 -0500 | Rating Details | |
| 2024-08-01 20:52:46 -0500 | Rating Details | |
| 2024-08-01 20:46:36 -0500 | Rating Details | |
| 2024-08-01 19:19:34 -0500 | Rating Details | |
| 2024-08-01 19:03:07 -0500 | Rating Details | |
| 2024-08-01 19:01:16 -0500 | Rating Details |